IC3 Antiplatelets Flashcards

1
Q

State the 4 stages of hemostasis

A
  1. Vasoconstriction
  2. Primary hemostasis
  3. Secondary hemostasis
  4. Clot stabilization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the 4 stages of hemostasis

A

Vasoconstriction
Reflex vasoconstriction occurs at the site of injury due to endothelin release from endothelial cells

Primary hemostasis
Platelets adhere & undergo a shape change to be activated → release ADP, TXA2 to recruit more platelets → stimulate further platelet aggregation (hemostatic plug)

Secondary hemostasis
The release of tissue factor causes phospholipid complex expression which activates prothrombin to thrombin → thrombin converts fibrinogen to fibrin, promoting fibrin polymerization

Clot stabilization
As platelet contracts, factor XIIIa is activated to stabilize fibrin → fibrin network matures (fibrin covalently cross links) → traps more platelet + blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which stage of hemostasis do Antiplatelets block?

A

Primary hemostasis
(platelet adhesion, activation. & aggregation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List the antiplatelet agents & what they inhibit

A

Dipyridamole
Adenosine uptake and PDE3 inhibitor
(prevents platelet activation)

Aspirin
COX-1 inhibitor
(prevents the production of cyclic endoperoxides from arachidonic acid, which is required for TXA2 synthesis)

Clopidogrel, Ticagrelor
ADP (P2Y12) receptor inhibitors
(prevents ADP release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What benefit can combining different antiplatelet agents confer?

A
  • Stronger antiplatelet effects, so used in those with higher thrombotic risks
  • But be careful to prevent excessive ↓hemostasis which can cause bruises & bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA of Dipyridamole?

A

cAMP inhibits platelet activation & aggregation

Inhibits platelet activation & aggregation by ↑cAMP within
platelets

1. Inhibits adenosine reuptake → ↑ plasma adenosine → ↑ activation of A2 receptors on inactive platelets → ↑ cAMP
2. Inhibits Phosphodiesterase 3 (PDE3) to ↓ degradation of cAMP within platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the indications of Dipyridamole?

A
  • Adjunct antiplatelet (low dose) in combination with other antiplatelets (e.g. aspirin) &/or anticoagulants (e.g. warfarin)
  • IV infusion as an alternative to exercise for myocardial perfusion imaging (due to its strong vasodilatory effects, it can trigger reflex tachycardia & ↑cardiac perfusion, simulating exercise)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is the role of Dipyridamole limited to an adjunct therapy?

A
  • Adenosine is a vasodilator
  • PDEs degrade cAMP, & cAMP is also a vasodilator
  • Since it inhibits adenosine reuptake & PDEs in vascular smooth muscle, it causes vasodilation (an adverse effect)
  • So the dose-limiting adverse effects limit its clinical antiplatelet efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is the onset of Dipyridamole?

A
  • Fast
  • 20 to 30 min after oral administration
  • Peak effect at 2 to 2.5h
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the DOA of Dipyridamole? Relate this to the formulation it is available in

A
  • Short DOA of ~3h
  • Hence usually available as MR preparation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is an advantage with regards to the DOA of Dipyridamole?

A

Rapid reversal if there are concerns on haemorrhage & bleeding risks compared to other classes of antiplatelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the adverse effects of Dipyridamole?

A
  • Headache
  • Hypotension
  • Dizziness
  • Flushing
    (vasodilatory effects)
  • GI disturbance
  • Diarrhoea
  • Nausea
  • Vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the respective contraindications & precaution with Dipyridamole use?

A

Contraindications
Hypersensitivity

Caution
Hypotension (Acute hypotension can trigger reflex tachycardia → angina pectoris & ECG abnormalities or even MI)
Severe coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 drug-drug interactions of concern for Dipyridamole?

A
  • ↑ Cardiac adenosine levels & effects
  • ↓ Cholinesterase inhibitors & may aggravate myasthenia gravis
  • Caution for bleeding when combined with 🥨 heparin or other anticoagulants & antiplatelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why does Aspirin have a stronger antiplatelet effect than other NSAIDs which are more potent at inhibiting COX-1 than COX-2?

A

Aspirin is the ONLY NSAID with 🥨irreversible effect on COX enzyme inhibition
Potency & reversibility are separate parameters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Apart from being an antiplatelet, what other indication does Aspirin have?

A

Analgesia
as it is a non-selective COX inhibitor (inhibits both COX-1 & COX-2)

17
Q

To reap the most antiplatelet effect, should Aspirin be used at low or high doses, & how frequently should they be taken? Explain why

A
  • Low dose OD e.g. 75 to 325 mg loading dose or 40 to 160 mg OD more effective than a high dose of e.g. 500 mg to 1g
  • Normally, Aspirin inhibits COX-1 > COX-2
  • If used at high doses, it will more strongly block PGI2 production for a longer duration (PGI2 inhibits platelet aggregation) → inhibit endogenous antiplatelet effects → more pro-platelet effect
  • So if used at low dose, it can irreversibly inhibit COX-1 then be cleared from plasma soon after (so no longer inhibit COX-2, allows recovery of endothelial cell production of PGI2)
  • Hence, OD dosing is also more effective than every 4 to 6h (which would be ideal for analgesic effects instead)
18
Q

Where are COX-1 enzymes expressed & what do they produce? Explain the function of what they produce

A
  • Expressed by platelets
  • Produce TXA2, which promotes platelet aggregation
19
Q

If the COX-1 enzyme is inhibited, how long does it take for recovery?

A
  • Takes 7 to 10 days
  • Because platelets have no nucleus & Aspirin irreversibly inhibits COX-1, new COX-1 enzymes cannot be produced unless new platelets are present
  • So effect can only be restored by formation of new platelets
  • & this takes 🥨 7 to 10 days
20
Q

Where are COX-2 enzymes expressed & what do they produce? Explain the function of what they produce

A
  • Endothelial cells
  • Produce PGI2, which inhibits platelet aggregation
21
Q

If the COX-2 enzyme is inhibited, how long does it take for recovery?

A
  • As endothelial cells have nucleus, they are able to synthesize new COX enzymes
  • So function can be recovered quite quickly, taking 3 to 4h
22
Q

Why does it take 3 to 4 hours to observe a clinically significant antiplatelet effect of Aspirin?

A
  • By 3 to 4h, low dose Aspirin would have been largely cleared
  • So the new COX-2 enzyme would be uninhibited (recall Aspirin is non-selective)
23
Q

When can maximum antiplatelet effects be seen & why?

A
  • Need 2 to 3 days of continuous daily administration for maximum effects
  • Because at low doses, not all platelets are inhibited
24
Q

What is the MOA of Aspirin?

A
  • Irreversible COX inhibitor (COX-1 > COX-2)
  • Inhibits platelet production of TXA2
25
Q

What are the adverse effects of Aspirin?

A
  1. Upper GI events e.g. gastric ulcers, bleeding
  2. ↑ risk of bruising & bleeding
26
Q

What are the precautions for Aspirin use?

A

In patients with platelet & bleeding disorders

27
Q

If Aspirin is combined with other antiplatelets & anticoagulants, watch out for ______

A

bleeding (like Dipyridamole)

28
Q

Why does Aspirin cause upper GI events (UGI)?

A
  • COX-1 produces protective prostaglandin in stomach which are involved in ↓ acid secretion, ↑ bicarbonate, mucus secretion, mucosal blood flow
  • But Aspirin inhibits such production by inhibiting COX-1
  • e.g. Low-dose aspirin indicated for cardioprotective effects is associated with a 2 to 4-fold ↑ in UGI events
29
Q

What is the MOA of ADP P2Y12 receptor inhibitors?

A
  • Prevents release of ADP from dense granules of platelets
  • ADP acts on ADP P2Y12 receptors & plays a central role in activating Glycoprotein IIb/IIIa receptors, platelet recruitment & aggregation
  • GP IIb/IIIa receptors subsequently bind to fibrinogen to link adjacent platelets together
30
Q

What are the similarities & differences of Clopidogrel & Ticagrelor?

A
  • Both are ADP P2Y12 receptor inhibitors
  • Binding site Clopidogrel is a prodrug with an active metabolite that binds to the ADP binding site on the P2Y12 inhibitor but Ticagrelor & its metabolites binds to a different site to inhibit G protein activation & signalling
  • Type of binding Clopidogrel binds irreversibly while Ticagrelor binds reversibly
  • Dosing frequency Clopidogrel often dosed OD while Ticagrelor is BD
  • Recovery of platelet function Clopidogrel’s effects on platelet function last for the lifetime of the affected platelets, which is ~7 to 10 days but Ticagrelor’s depend on its serum concentrations & its active metabolites, takes 2 to 3 days (faster offset)
  • Time to onset, peak effects Ticagelor has a faster onset & peak effect than Clopidogrel
31
Q

Suggest why a delayed onset & inter-individual variability is often observed for Clopidogrel

A

CYP2C19-mediated metabolism causes the production of active metabolite, causing a delayed onset (peak action 6 to 8h) & inter-individual variability

32
Q

How would you expect Prasugrel’s properties to be?

A
  • Likely more similar to Clopidogrel than Ticagrelor “grel”
  • A prodrug, binds irreversibly
  • It is actually slightly more potent & largely dependent on CYP3A4 & CYP2D6 for metabolism
33
Q

Which antiplatelet class uses loading-dose regimens to accelerate approach to steady state?

A

ADP P2Y12 inhibitors

34
Q

Compare the adverse effects of Clopidogrel & Ticagrelor

A

Clopidogrel
Haemorrhage/bleeding, including intracranial bleeding
Easy bruising
Dyspepsia, rashes
Bronchospasm
(more rarely) Dyspnea, hypotension

Ticagrelor
Haemorrhage/bleeding, including intracranial bleeding
Easy bruising
Bradycardia
Cough
Dyspnea

35
Q

Compare the contraindications of Clopidogrel & Ticagrelor

A

Clopidogrel
Hypersensitivity
Active pathologic bleeding

Ticagrelor
Hypersensitivity
Active pathologic bleeding or intracranial hemorrhage
Severe hepatic impairment
Breastfeeding women

36
Q

Compare the precautions of Clopidogrel & Ticagrelor

A

Clopidogrel
At risk of bleeding (e.g. risk of intracranial haemorrhage, trauma, surgery)
Variant alleles of CYP2C19 associated with ↓metabolism to active metabolite & diminished antiplatelet response (causing ↑use of Prasugrel as an alternative)

Ticagrelor
At risk of bleeding (e.g. risk of intracranial haemorrhage, trauma, surgery)
Elderly
Moderate hepatic failure

37
Q

What are the drug-drug interactions of concern for Clopidogrel?

A
  1. Increase risk of bleeding
    Warfarin, NSAIDs & salicylates
    Rifamycins may increase the antiplatelet effect
  2. May reduce the antiplatelet effect
    Macrolides
    Strong to moderate CYP2C19 inhibitors (e.g. PPIs, fluoxetine, ketoconazole etc) may reduce the antiplatelet effect
38
Q

What are the drug-drug interactions of concern for Ticagrelor?

A
  1. Anticoagulants, fibrinolytics, & long-term NSAIDs may ↑bleeding risk
  2. Aspirin doses >100 mg/day ↓Ticagrelor effect but ↑bleeding risk (DON’T DO THIS)
  3. CYP3A inducers (e.g. dexamethasone, phenytoin, etc) may ↓Ticagrelor level & antiplatelet effect
  4. CYP3A strong inhibitors (e.g. clarithromycin, ketoconazole etc) may
    ↑Ticagrelor level & risk of adverse reactions
39
Q

Rank the following drugs based on how quickly their antiplatelet effects would reverse upon discontinuation (fastest to slowest):
Aspirin, Dipyridamole, Ticagrelor, Clopidogrel

A

Dipyridamole > Ticagrelor > Clopidogrel > Aspirin